Research Article
Conventional Interferon Therapy Response among Chronic HCV Patients in Khyber Pakhtunkhwa
Bashir Ahmad1 Sajid Ali1* Ijaz Ali2 Nourin Mahmood1 Shumaila Bashir3 Shoaib Nawaz4 | ||
1Centre for Biotechnology and Microbiology, University of Peshawar, Peshawar, Khyber Pakhtunkhwa, Pakistan | ||
2Institute of Biotechnology and Genetic Engineering, Agricultural University, Peshawar, Khyber Pakhtunkhwa, Pakistan | ||
3Departmet of Pharmacy, University of Peshawar, Peshawar, Khyber Pakhtunkhwa, Pakistan | ||
4Department of Biotechnology, Kohat university of Science and Technology, Kohat, Khyber Pakhtunkhwa, Pakistan | ||
Corresponding Author : | Sajid Ali Centre for Biotechnology and Microbiology University of Peshawar, Peshawar Khyber Pakhtunkhwa, Pakistan E-mail: vet_sajid@yahoo.com |
|
Received March 11, 2013; Accepted April 24, 2013; Published April 27, 2013 | ||
Citation: Ahmad B, Ali S, Ali I, Mahmood N, Bashir S, et al. (2013) Conventional Interferon Therapy Response among Chronic HCV Patients in Khyber Pakhtunkhwa. J Infect Dis Ther 1:104. doi: 10.4172/2332-0877.1000104 | ||
Copyright: © 2013 Ahmad B, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. | ||
Related article at![]() ![]() |
Abstract
As Hepatitis C infection is the cause of hundreds of thousands of deaths worldwide including Pakistan. Different regions have different infection rates in Pakistan and hence different mortality. Khyber Pakhtunkhwa (KPK) is one of the main affected provinces of the country. Since Interferon (IFN) based therapy is used to eradicate the infection from the bodies of infected individuals. However information regarding treatment response in different population groups in case of chronic HCV patients is lacking. So it is aimed to investigate response rates of IFN and Ribavirin combination therapy in different districts of KPK.